Filing Details

Accession Number:
0001209191-19-031916
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-22 09:10:05
Reporting Period:
2019-05-21
Accepted Time:
2019-05-22 09:10:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566373 Spring Bank Pharmaceuticals Inc. SBPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1339402 J Martin Driscoll C/O Spring Bank Pharmaceuticals, Inc.
35 Parkwood Drive
Hopkinton MA 01748
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-21 5,000 $6.63 75,400 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct